Skip to contentK
Kyntra Bio, Inc.
K
KYNBKyntra Bio, Inc. Q2 2017 · 10-Q
Revenue$30.27M$30.27M−66.1% vs Q2 2016 Net Income-$31.91M-$31.91MN/M vs Q2 2016 EPS Diluted-$0.48-$0.48N/M vs Q2 2016 Operating Income-$30,138,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$20,734,000N/M Margins · derivedOperating margin-99.6%−129.3 pt vs Q2 2016
Net margin-105.4%−132.7 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 7, 2017 · 38 d after period end